Page last updated: 2024-11-07

metaraminol and Aortic Diseases

metaraminol has been researched along with Aortic Diseases in 2 studies

Metaraminol: A sympathomimetic agent that acts predominantly at alpha-1 adrenergic receptors. It has been used primarily as a vasoconstrictor in the treatment of HYPOTENSION.
metaraminol : A member of the class of phenylethanolamines that is 2-amino-1-phenylethanol substituted by a methyl group at position 2 and a phenolic hydroxy group at position 1. A sympathomimetic agent , it is used in the treatment of hypotension.

Aortic Diseases: Pathological processes involving any part of the AORTA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
JASMIN, G1
Davies, MJ1
Silbert, BS1
Mooney, PJ1
Dysart, RH1
Meads, AC1

Trials

1 trial available for metaraminol and Aortic Diseases

ArticleYear
Combined epidural and general anaesthesia versus general anaesthesia for abdominal aortic surgery: a prospective randomised trial.
    Anaesthesia and intensive care, 1993, Volume: 21, Issue:6

    Topics: Aged; Analgesia; Analgesia, Epidural; Anesthesia, Epidural; Anesthesia, General; Aorta, Abdominal; A

1993

Other Studies

1 other study available for metaraminol and Aortic Diseases

ArticleYear
CARDIAC, AORTIC AND PULMONARY LESIONS INDUCED BY VASOPRESSORS.
    Vascular diseases, 1965, Volume: 2

    Topics: Aortic Diseases; Blood Chemical Analysis; Calcinosis; Heart Diseases; Histocytochemistry; Hypercalce

1965